Cerebral Amyloid Angiopathy: Clinicopathologic Features and Pathogenesis
暂无分享,去创建一个
[1] H. Vinters,et al. Neuropathologic analysis of hematomas evacuated from patients with spontaneous intracerebral hemorrhage , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.
[2] Maja A. A. Binnewijzend,et al. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.
[3] E. Eugenin,et al. Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans. , 2013, The Journal of infectious diseases.
[4] J. Baron,et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy , 2013, Neurology.
[5] P. Hof,et al. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.
[6] Brian J. Bacskai,et al. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models , 2013, Acta Neuropathologica.
[7] H. Vinters,et al. A Shift in Microglial β‐Amyloid Binding in Alzheimer's Disease Is Associated with Cerebral Amyloid Angiopathy , 2013, Brain pathology.
[8] Yi-lin Sun,et al. The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population , 2013, Neurosurgical Review.
[9] Antonio Colombo,et al. Anti–amyloid β autoantibodies in cerebral amyloid angiopathy–related inflammation: Implications for amyloid‐modifying therapies , 2013, Annals of neurology.
[10] M. Colado,et al. A study on the effect of JNK inhibitor, SP600125, on the disruption of blood–brain barrier induced by methamphetamine , 2013, Neurobiology of Disease.
[11] C. Iadecola,et al. Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain , 2013, Stroke.
[12] M. Toborek,et al. Infection of human pericytes by HIV-1 disrupts the integrity of the blood–brain barrier , 2012, Journal of cellular and molecular medicine.
[13] L. Grinberg,et al. Cerebral amyloid angiopathy impact on endothelium , 2012, Experimental Gerontology.
[14] Bojana Stefanovic,et al. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. , 2012, Brain : a journal of neurology.
[15] S. Masino,et al. Ketone bodies protection against HIV‐1 Tat‐induced neurotoxicity , 2012, Journal of neurochemistry.
[16] J. Geiger,et al. Role of endolysosomes in HIV-1 Tat-induced neurotoxicity , 2012, ASN neuro.
[17] À. Rovira,et al. MMP‐2/MMP‐9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy‐Associated Hemorrhagic Stroke , 2012, Brain pathology.
[18] D. Strayer,et al. Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications , 2012, TheScientificWorldJournal.
[19] H. Weiner,et al. Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model , 2012, Neurobiology of Aging.
[20] L. Cortellini,et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy , 2012, Neurology.
[21] Colin Smith,et al. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[22] M. Frosch,et al. Differential recognition of vascular and parenchymal beta amyloid deposition , 2011, Neurobiology of Aging.
[23] Guoku Hu,et al. Platelet-Derived Growth Factor B Chain Is a Novel Target Gene of Cocaine-Mediated Notch1 Signaling: Implications for HIV-Associated Neurological Disorders , 2011, The Journal of Neuroscience.
[24] C. Sudlow,et al. Genetic associations with brain microbleeds , 2011, Neurology.
[25] H. Vinters. Inflammation Complicates an ‘Age-Related’ Cerebral Microangiopathy , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[26] A. Easton,et al. Amyloid β-related Angiitis of the Central Nervous System: Report of 3 Cases , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[27] J. Clements,et al. Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood–Brain Barrier Integrity by a Gap Junction-Dependent Mechanism , 2011, The Journal of Neuroscience.
[28] Honghong Yao,et al. Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability , 2011, PloS one.
[29] Susan Morgello,et al. Cocaine Hijacks σ1 Receptor to Initiate Induction of Activated Leukocyte Cell Adhesion Molecule: Implication for Increased Monocyte Adhesion and Migration in the CNS , 2011, The Journal of Neuroscience.
[30] S. Love,et al. Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ‐Induced Degeneration of Cerebrovascular Smooth Muscle Cells , 2011, Brain pathology.
[31] Honghong Yao,et al. HIV-1 Tat-Mediated Induction of Platelet-Derived Growth Factor in Astrocytes: Role of Early Growth Response Gene 1 , 2011, The Journal of Immunology.
[32] D. Holtzman,et al. Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.
[33] S. Leurgans,et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons , 2011, Annals of neurology.
[34] C. Cordonnier. Brain microbleeds: more evidence, but still a clinical dilemma. , 2011, Current opinion in neurology.
[35] M. Churchill,et al. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia , 2011, Journal of NeuroVirology.
[36] J. Attems,et al. Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology , 2010, Journal of the Neurological Sciences.
[37] H. Vinters,et al. Aquaporin Expression in the Brains of Patients With or Without Cerebral Amyloid Angiopathy , 2010, Journal of neuropathology and experimental neurology.
[38] H. Vinters,et al. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease. , 2010, Human pathology.
[39] W. Freeman,et al. Spontaneous Intracerebral Hemorrhage , 2010, Seminars in neurology.
[40] C. Wessig,et al. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. , 2010, Human molecular genetics.
[41] A. Nath,et al. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. , 2010, The American journal of pathology.
[42] S. Marks,et al. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis , 2010, Pediatric Nephrology.
[43] E. V. Van Bockstaele,et al. HIV-1 gp120-Induced Injury to the Blood-Brain Barrier: Role of Metalloproteinases 2 and 9 and Relationship to Oxidative Stress , 2010, Journal of neuropathology and experimental neurology.
[44] Peter H Lin,et al. HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. , 2010, Cardiovascular research.
[45] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[46] E. V. Bockstaele,et al. Blood–brain barrier abnormalities caused by exposure to HIV-1 gp120 — Protection by gene delivery of antioxidant enzymes , 2010, Neurobiology of Disease.
[47] H. Vinters,et al. Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy , 2010, Brain pathology.
[48] E. Mark Haacke,et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study , 2010, Acta Neuropathologica.
[49] E. V. Bockstaele,et al. HIV-1 gp120-induced neuroinflammation: Relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes , 2010, Experimental Neurology.
[50] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[51] Honghong Yao,et al. TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway , 2009, Cell Death and Differentiation.
[52] Hidekazu Tomimoto,et al. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia , 2009, Neuroreport.
[53] E. V. Bockstaele,et al. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: Protection by rSV40 delivery of antioxidant enzymes , 2009, Neurobiology of Disease.
[54] M. Toborek,et al. PPARα and PPARγ attenuate HIV‐induced dysrégulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] G. Plant,et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.
[56] Honghong Yao,et al. Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity , 2009, The Journal of Neuroscience.
[57] K. Martemyanov,et al. Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death , 2008, The Journal of Neuroscience.
[58] M. Toborek,et al. Caveolin-1 Regulates Human Immunodeficiency Virus-1 Tat-Induced Alterations of Tight Junction Protein Expression via Modulation of the Ras Signaling , 2008, The Journal of Neuroscience.
[59] Ulf Eriksson,et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.
[60] Fredrik Lanner,et al. Notch Signaling Regulates Platelet-Derived Growth Factor Receptor-β Expression in Vascular Smooth Muscle Cells , 2008, Circulation research.
[61] M. Toborek,et al. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood–brain barrier , 2007, Brain Research.
[62] E. V. Bockstaele,et al. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors , 2007, Gene Therapy.
[63] J. Berman,et al. Gap Junctions Mediate Human Immunodeficiency Virus-Bystander Killing in Astrocytes , 2007, The Journal of Neuroscience.
[64] E. Masliah,et al. Transgenic animal models of neurodegenerative diseases and their application to treatment development. , 2007, Advanced drug delivery reviews.
[65] Keith A. Johnson,et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.
[66] H. Vinters. Imaging cerebral microvascular amyloid , 2007, Annals of neurology.
[67] J. Geiger,et al. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-α-mediated neurotoxicity , 2007, Neurobiology of Disease.
[68] Howard E Gendelman,et al. HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral Neuropathogenesis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[69] Shuxian Hu,et al. Morphine stimulates CCL2 production by human neurons , 2006, Journal of Neuroinflammation.
[70] E. V. Bockstaele,et al. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis , 2006, Gene Therapy.
[71] Chris Zarow,et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.
[72] M. di Luca,et al. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice , 2006, BMC Neuroscience.
[73] O. Selnes,et al. Vascular cognitive impairment , 2006, Nature Clinical Practice Neurology.
[74] M. Toborek,et al. HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood–Brain Barrier , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[75] E. Englund,et al. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia , 2006, International journal of geriatric psychiatry.
[76] H. Vinters,et al. Effects of Anoxia and Hypoxia on Amyloid Precursor Protein Processing in Cerebral Microvascular Smooth Muscle Cells , 2006, Journal of neuropathology and experimental neurology.
[77] Y. Matsumoto,et al. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis , 2006, Acta Neuropathologica.
[78] G. Lammie,et al. Hypertensive cerebral small vessel disease and stroke. , 2006, Brain pathology.
[79] A. Nath,et al. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. , 2006, Neurotoxicology.
[80] Mathias Jucker,et al. Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .
[81] M. Frosch,et al. The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .
[82] M. Jaskólski,et al. The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models , 2006, Brain pathology.
[83] T. Golde,et al. Anti-Aβ42– and anti-Aβ40–specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model , 2005 .
[84] A. Paetau,et al. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype , 2005, Neuropathology and applied neurobiology.
[85] M. Toborek,et al. Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[86] John Hardy,et al. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.
[87] Irene Otte-Höller,et al. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.
[88] Chuanful Li,et al. HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[89] Marlys Witte,et al. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells , 2005, Journal of NeuroVirology.
[90] Brian J Bacskai,et al. Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.
[91] J. Hardy,et al. Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice , 2005, Neuron.
[92] J. Holton,et al. Chromosome 13 dementias , 2005, Cellular and Molecular Life Sciences CMLS.
[93] Donald W. Miller,et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. , 2005, Alcoholism, clinical and experimental research.
[94] J. Reynolds,et al. Cocaine Modulates Dendritic Cell-Specific C Type Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Expression by Dendritic Cells in HIV-1 Patients1 , 2005, The Journal of Immunology.
[95] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[96] P. Grammas,et al. HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia , 2005, Journal of neuropathology and experimental neurology.
[97] W. Banks,et al. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells , 2005, Brain Research.
[98] James L. Buescher,et al. Overexpression of monocyte chemotactic protein-1/ CCL2 in β-amyloid precursor protein transgenic mice show accelerated diffuse β-amyloid deposition , 2005 .
[99] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[100] S. Love,et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .
[101] D. Dickson,et al. Extracellular Deposits of Aβ Produced in Cultures of Alzheimer Disease Brain Vascular Smooth Muscle Cells , 2005 .
[102] F. Schmitt,et al. Neuroimaging correlates of HIV-associated BBB compromise , 2004, Journal of Neuroimmunology.
[103] J. Bell,et al. An update on the neuropathology of HIV in the HAART era , 2004, Histopathology.
[104] B. Clurman,et al. Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression , 2004, Molecular and Cellular Biology.
[105] M. Mayo,et al. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.
[106] J. Nicoll,et al. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage , 2004, The Lancet Neurology.
[107] D. Antonetti,et al. Regulation of tight junctions and loss of barrier function in pathophysiology. , 2004, The international journal of biochemistry & cell biology.
[108] A. Beaudet,et al. Morphine-Induced Changes in δ Opioid Receptor Trafficking Are Linked to Somatosensory Processing in the Rat Spinal Cord , 2004, The Journal of Neuroscience.
[109] Eric E. Smith,et al. Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage , 2004, Stroke.
[110] R. Deane,et al. Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor* , 2004, Journal of Biological Chemistry.
[111] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[112] A. Karsan,et al. Notch4 Inhibits Endothelial Apoptosis via RBP-Jκ-dependent and -independent Pathways* , 2004, Journal of Biological Chemistry.
[113] K. Jellinger,et al. Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology , 2004, Acta Neuropathologica.
[114] J. Malter,et al. Anti‐Aβ: The good, the bad, and the unforeseen , 2004 .
[115] M. Frosch,et al. Clinical manifestations of cerebral amyloid angiopathy–related inflammation , 2004, Annals of neurology.
[116] K. Jellinger,et al. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study , 2004, Acta Neuropathologica.
[117] J. Esteban,et al. Living with the enemy: a physiological role for the β-amyloid peptide , 2004, Trends in Neurosciences.
[118] I. Ferrer,et al. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.
[119] O. Wiestler,et al. Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.
[120] K. Hinokuma,et al. Subcortical hematoma caused by cerebral amyloid angiopathy: Does the first evidence of hemorrhage occur in the subarachnoid space? , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.
[121] M. Wolfe,et al. Identity and function of γ‐secretase , 2003 .
[122] N. Hooper,et al. ADAMs family members as amyloid precursor protein α‐secretases , 2003 .
[123] Christina A. Wilson,et al. Distinct presenilin‐dependent and presenilin‐independent γ‐secretases are responsible for total cellular Aβ production , 2003 .
[124] Bernhard Hennig,et al. HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells , 2003, Journal of neuroscience research.
[125] M. Verbeek,et al. Pathogenesis of cerebral amyloid angiopathy , 2003, Brain Research Reviews.
[126] D. Graham,et al. Association Between Interleukin-1A Polymorphism and Cerebral Amyloid Angiopathy–Related Hemorrhage , 2003, Stroke.
[127] A. Nath,et al. Synaptic Transport of Human Immunodeficiency Virus-Tat Protein Causes Neurotoxicity and Gliosis in Rat Brain , 2003, The Journal of Neuroscience.
[128] D. Holtzman,et al. Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy , 2003, Annals of neurology.
[129] G. Plant,et al. Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.
[130] R. Weller,et al. A new role for astrocytes: β-amyloid homeostasis and degradation , 2003 .
[131] G. Mckhann,et al. Clinicopathological review: primary angiitis of the central nervous system in association with cerebral amyloid angiopathy. , 2003, Neurosurgery.
[132] M. Yamada,et al. Association of neprilysin polymorphism with cerebral amyloid angiopathy , 2003, Journal of neurology, neurosurgery, and psychiatry.
[133] J. Frackowiak,et al. Secretion and Accumulation of Aβ by Brain Vascular Smooth Muscle Cells from AβPP‐Swedish Transgenic Mice , 2003 .
[134] W. V. Van Nostrand,et al. Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cells , 2003 .
[135] F. Scaravilli,et al. The Changing Pattern of HIV Neuropathology in the HAART Era , 2003, Journal of neuropathology and experimental neurology.
[136] N. Sacktor,et al. Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.
[137] H. Vinters,et al. Smooth muscle cells and the pathogenesis of cerebral microvascular disease ("angiomyopathies"). , 2003, Experimental and molecular pathology.
[138] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[139] R. Ransohoff,et al. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). , 2003, Seminars in immunology.
[140] Yong Woo Lee,et al. HIV‐Tat protein induces oxidative and inflammatory pathways in brain endothelium , 2002, Journal of neurochemistry.
[141] E. Masliah,et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis , 2002, Neurology.
[142] M. Staufenbiel,et al. Cerebral Hemorrhage After Passive Anti-Aβ Immunotherapy , 2002, Science.
[143] S. D. Preston,et al. Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain , 2002 .
[144] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[145] Ulf Eriksson,et al. Angiogenesis stimulated by PDGF‐CC, a novel member in the PDGF family, involves activation of PDGFR‐aa and ‐ap receptors , 2002 .
[146] M. Marcinkiewicz,et al. Declining Expression of Neprilysin in Alzheimer Disease Vasculature: Possible Involvement in Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.
[147] R. Nitsch,et al. Aβ42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo * , 2002, The Journal of Biological Chemistry.
[148] Jiankun Cui,et al. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.
[149] H. Vinters,et al. Tissue Microarrays in the Study of Non‐Neoplastic Disease of the Nervous System , 2002, Journal of neuropathology and experimental neurology.
[150] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[151] Hartwig Wolburg,et al. Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.
[152] H. Vinters,et al. Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: cellular responses and expression of cerebral amyloid angiopathy‐associated proteins , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[153] E. Major,et al. HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. , 2002, Microbes and infection.
[154] H. Braak,et al. Two Types of Sporadic Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.
[155] Taku Sugawara,et al. Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[156] R. Roos,et al. Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.
[157] Yong Woo Lee,et al. Cocaine activates redox-regulated transcription factors and induces TNF-α expression in human brain endothelial cells , 2001, Brain Research.
[158] M. Wolfe,et al. A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.
[159] D. Markovitz,et al. Human Immunodeficiency Virus Type 1 (HIV-1)-Induced GRO-α Production Stimulates HIV-1 Replication in Macrophages and T Lymphocytes , 2001, Journal of Virology.
[160] T. Grabowski,et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.
[161] A. Lackner,et al. Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques , 2001, The Journal of experimental medicine.
[162] M. Staufenbiel,et al. Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.
[163] S. Greenberg,et al. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.
[164] W. Jagust,et al. Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.
[165] A. Bansal,et al. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.
[166] Andreas Hufnagel,et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) , 2000, Journal of neurology, neurosurgery, and psychiatry.
[167] R. A. Frommelt,et al. Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies , 2000, Journal of neuropathology and experimental neurology.
[168] A. Fagan,et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.
[169] L. Thal,et al. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.
[170] S. D. House,et al. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. , 2000, Life sciences.
[171] I. Tesseur,et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons , 2000, Neurobiology of Aging.
[172] B. Urmoneit,et al. Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular Aβ Clearance , 2000, Annals of the New York Academy of Sciences.
[173] H. Vinters,et al. Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. , 2000, Stroke.
[174] Melina V Jones,et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.
[175] J. Christman,et al. Redox Regulation of Nuclear Factor Kappa B: Therapeutic Potential for Attenuating Inflammatory Responses , 2000, Brain pathology.
[176] O. Finco,et al. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. , 1999, AIDS.
[177] C. Achim,et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.
[178] P. Cheney,et al. Microglial Activation and Neurological Symptoms in the SIV Model of NeuroAIDS: Association of MHC-II and MMP-9 Expression with Behavioral Deficits and Evoked Potential Changes , 1999, Neurobiology of Disease.
[179] B. Sommer,et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[180] A. Nath,et al. Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.
[181] M. Fujimura,et al. Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[182] S. Love,et al. Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors , 1999 .
[183] M. Didier-Bazès,et al. Spatiotemporal Expression Patterns of Metalloproteinases and Their Inhibitors in the Postnatal Developing Rat Cerebellum , 1999, The Journal of Neuroscience.
[184] L Zhang,et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. , 1999, Clinical immunology.
[185] S. Croul,et al. Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.
[186] S. L. Chang,et al. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. , 1998, Clinical immunology and immunopathology.
[187] G. Rosenberg,et al. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.
[188] S. Greenberg,et al. Cerebral amyloid angiopathy , 1998, Neurology.
[189] S. Greenberg,et al. Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy , 1998, Neurology.
[190] R. Roos,et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) , 1998, Acta Neuropathologica.
[191] W. V. Van Nostrand,et al. Pathologic Amyloid β‐Protein Cell Surface Fibril Assembly on Cultured Human Cerebrovascular Smooth Muscle Cells , 1998 .
[192] L. Mucke,et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.
[193] L. Walker,et al. Animal models of cerebral β-amyloid angiopathy , 1997, Brain Research Reviews.
[194] O. Finco,et al. Induction of CD4+ T cell depletion in mice doubly transgenic for HIV gp120 and human CD4 , 1997, European journal of immunology.
[195] D. Graham,et al. High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy , 1997, Annals of neurology.
[196] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[197] L. Thal,et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.
[198] M. Yamada,et al. Immune reactions associated with cerebral amyloid angiopathy. , 1996, Stroke.
[199] L. Thal,et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease , 1996, Neurology.
[200] C. Sen,et al. Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[201] Gary A. Rosenberg,et al. Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[202] H. Vinters,et al. Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease , 1996, Brain pathology.
[203] J. Davis-Salinas,et al. Amyloid β‐Protein Induces the Cerebrovascular Cellular Pathology of Alzheimer's Disease and Related Disorders a , 1996 .
[204] N. Fountain,et al. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 1996, Neurology.
[205] W. V. Van Nostrand,et al. Amyloid β-Protein Aggregation Nullifies Its Pathologic Properties in Cultured Cerebrovascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.
[206] C. Cotman,et al. Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells , 1995 .
[207] L. Thal,et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.
[208] H. Wiśniewski,et al. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs , 1995, Brain Research.
[209] H. Wiśniewski,et al. Non‐Fibrillar β‐Amyloid Protein is Associated with Smooth Muscle Cells of Vessel Walls in Alzheimer Disease , 1994, Journal of neuropathology and experimental neurology.
[210] H. Vinters,et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. , 1994, Ultrastructural Pathology.
[211] N. Morisaki,et al. Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factor , 1994, Journal of cellular physiology.
[212] P. Stewart,et al. Re‐evaluating the role of astrocytes in blood‐brain barrier induction , 1993, Developmental Dynamics.
[213] R. Ransohoff,et al. Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[214] H. Vinters,et al. A morphometric study of the blood-brain barrier in Alzheimer's disease. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[215] J. Vonsattel,et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.
[216] C. Masters,et al. Surgical risk of hemorrhage in cerebral amyloid angiopathy. , 1991, Stroke.
[217] H. Vinters,et al. Cerebral amyloid angiopathy and granulomatous angiitis: immunohistochemical study using antibodies to the Alzheimer A4 peptide. , 1990, Human pathology.
[218] H. Vinters,et al. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.
[219] D. Ramsay,et al. Fatal Streptokinase-Induced Intracerebral Haemorrhage in Cerebral Amyloid Angiopathy , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[220] M. Brightman,et al. Development of membrane interactions between brain endothelial cells and astrocytes in vitro , 1988, International Journal of Developmental Neuroscience.
[221] G. Lutty,et al. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[222] G. Goldstein,et al. Endothelial Cell‐Astrocyte Interactions , 1988, Annals of the New York Academy of Sciences.
[223] C. Bergeron,et al. Amyloid Angiopathy in Alzheimer's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[224] Z. Nagy,et al. Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[225] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[226] M. Hirsch,et al. Immunohistochemical identification of HTLV‐III antigen in brains of patients with AIDS , 1986, Annals of neurology.
[227] T. Mandybur. Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications , 1986, Journal of neuropathology and experimental neurology.
[228] J. Girvin,et al. Isolation and culture of cells derived from human cerebral microvessels , 1985, Cell and Tissue Research.
[229] S. Weiss,et al. Oxidative autoactivation of latent collagenase by human neutrophils. , 1985, Science.
[230] A. Sima,et al. The Value of Histopathological Examination of Surgically Removed Blood Clot in Determining the Etiology of Spontaneous Intracerebral Hemorrhagef , 1984, Stroke.
[231] H. Vinters,et al. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. , 1983, Stroke.
[232] H. Vinters,et al. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.
[233] K. Jellinger,et al. Cerebrovascular amyloidosis with cerebral hemorrhage , 1977, Journal of Neurology.
[234] Rodney A. Bales,et al. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia , 2011, Journal of NeuroVirology.
[235] S. Nag. Morphology and properties of astrocytes. , 2011, Methods in molecular biology.
[236] Yaakov Stern,et al. HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.
[237] K. Jellinger. The pathology of "vascular dementia": a critical update. , 2008, Journal of Alzheimer's disease : JAD.
[238] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[239] C. Iadecola,et al. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.
[240] A. Palsdottir,et al. Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. , 2006, Brain pathology.
[241] Francisco González-Scarano,et al. The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.
[242] M. Rossor,et al. NEUROLOGICAL INFECTION AND INFLAMMATION , 2004, Journal of Neurology Neurosurgery & Psychiatry.
[243] M. Viitanen,et al. The Neuropathology of Dementia: Vascular dementias , 2004 .
[244] H. Vinters,et al. Neuropathologic Features and Grading of Alzheimer-Related and Sporadic CAA , 2000 .
[245] L. Mucke,et al. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.
[246] J. Tekstra,et al. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. , 1999, The American journal of pathology.
[247] D. Taub,et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. , 1998, Journal of neurovirology.
[248] S. D. House,et al. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? , 1998, Advances in experimental medicine and biology.